References
- Rachman S. A cognitive theory of obsessions. Behav Res Ther 1997;35:793–802.
- Salkovskis PM. Understanding and treating obsessive-compulsive disorder. Behav Res Ther 1999;37:29–52.
- Obsessive Compulsive Cognitions Working Group. Development and initial validation of the obsessive beliefs questionnaire and the interpretation of intrusions inventory. Behav Res Ther 2001;39:987–1006.
- Obsessive Compulsive Cognitions Working Group. Psychometric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory: Part I. Behav Res Ther 2003;41:863–78.
- Obsessive Compulsive Cognitions Working Group. Psychometric validation of the Obsessive Belief Questionnaire and Interpretation of Intrusions Inventory: Part 2, factor analyses and testing of a brief version. Behav Res Ther 2005;43:1527–42.
- Pigott TA, Seay S. Pharmacotherapy of OCD. Int Rev Psychiatry 1997;9:133–47.
- Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, . The Yale-Brown Obsessive Compulsive Scale. I. Development, use and reliability. Arch Gen Psychiatry 1989;46:1006–11.
- Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967:278–96.
- Akdemir A, Turkcapar H, Orsel SD, Demirergi N, Dag I, Ozbay H. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 2001;42:161–5.
- Tek C, Uluğ B, Rezaki BG, Tanriverdi N, Mercan S, Demir B, . Yale-Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity. Acta Psychiatr Scand 1995;91:410–13.
- Boysan M, Beşiroğlu L, Çetinkaya N, Atlı A, Aydın A. The validity and reliability of the Turkish version of the obsessive beliefs Questionnaire-44 (OBQ-44). Arch Neuropsychiatry 2010;47:216–22.
- Denys D, Femke de Geus MA, Van Megen HGJM, Westenberg HG. A double blind, randomized, placebo-controlled trial od quetiapine in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004;65:1040–8.
- March JS, Frances A, Kahn DA, Carpenter D. The expert consensus guidelines series: treatment of obsessive–compulsive disorder. J Clin Psychopharmacol 1997;58:4–64.
- Overbeek T, Schruers K, Vermetten E, Griez E. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002;63:1106–12.
- Uguz F, Askin R, Cilli AS, Besiroglu L. Comparison of treatment responses and clinical characteristics of early-onset and late-onset obsessive-compulsive disorder. Int J Psychiatry Clin Pract 2006;10:291–6.
- Besiroglu L, Cetinkaya N, Selvi Y, Atli A. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions and thought suppression in obsessive-compulsive disorder. Compr Psychiatry (in press).
- Purdon C, Clark D. Obsessive intrusive thoughts in nonclinical subjects. Part 1. Content and relation with depressive, anxious and obsessional symptoms. Behav Res Ther 1993;31:713–20.
- Salkovskis P. Obsessional-compulsive problems: A cognitive-behavioural analysis. Behav Res Ther 1985;23:571–83.
- Solem S, Håland AT, Vogel PA, Hansen B, Wells A. Change in metacognitions predicts outcome in obsessive-compulsive disorder patients undergoing treatment with exposure and response prevention. Behav Res Ther 2009; 47:301–7.
- Egan SJ, Wade TD, Shafran R. Perfectionism as a transdiagnostic process: A clinical review. Clin Psychol Rev 2011;31(2):203–12.
- Freeston M, Rheaume J, Ladouceur R. Correcting faulty appraisals of obsessional thougths. Behav Res Ther 1996;34:433–46.